feed,title,long_url,short_url
🔐MarketWatch,Sarepta down 11% on speculation over looming FDA rejection of DMD gene therapy,https://www.marketwatch.com/bulletins/redirect/go?g=%7B78B19766-EF69-4F61-997E-025DFA249F23%7D&siteid=bulletrss,https://da.gd/x6gkc
